Home/Radiance Biopharma/Robert Brooks, JD
RB

Robert Brooks, JD

Chief Executive Officer

Radiance Biopharma

Therapeutic Areas

Radiance Biopharma Pipeline

DrugIndicationPhase
RB-601Cancer (tumors expressing c-MET and EGFR)Pre-clinical
RB-203Cancer (tumors expressing membrane Hsp70)Pre-clinical